| Product Code: ETC8683398 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Oman Artificial Intelligence (AI) in Drug Discovery Market Overview |
3.1 Oman Country Macro Economic Indicators |
3.2 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 Oman Artificial Intelligence (AI) in Drug Discovery Market - Industry Life Cycle |
3.4 Oman Artificial Intelligence (AI) in Drug Discovery Market - Porter's Five Forces |
3.5 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Offering, 2021 & 2031F |
3.9 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.10 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Oman Artificial Intelligence (AI) in Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing research and development activities in the pharmaceutical industry |
4.2.2 Growing demand for personalized medicine |
4.2.3 Advancements in artificial intelligence technology |
4.3 Market Restraints |
4.3.1 High initial costs associated with implementing AI in drug discovery |
4.3.2 Concerns regarding data privacy and security |
4.3.3 Lack of skilled professionals in AI and drug discovery domain |
5 Oman Artificial Intelligence (AI) in Drug Discovery Market Trends |
6 Oman Artificial Intelligence (AI) in Drug Discovery Market, By Types |
6.1 Oman Artificial Intelligence (AI) in Drug Discovery Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Novel Drug Candidates, 2021- 2031F |
6.1.4 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Drug Optimization and Repurposing Preclinical Testing and Approval, 2021- 2031F |
6.1.5 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Drug Monitoring, 2021- 2031F |
6.1.6 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Aggregating and Synthesizing Information, 2021- 2031F |
6.1.7 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Formation and Qualification of Hypotheses, 2021- 2031F |
6.1.8 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By De Novo Drug Design, 2021- 2031F |
6.1.9 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Oman Artificial Intelligence (AI) in Drug Discovery Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Machine Learning, 2021- 2031F |
6.2.3 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Deep Learning, 2021- 2031F |
6.2.4 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Natural Language Processing, 2021- 2031F |
6.2.5 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Oman Artificial Intelligence (AI) in Drug Discovery Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Small Molecule, 2021- 2031F |
6.3.3 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Large Molecule, 2021- 2031F |
6.4 Oman Artificial Intelligence (AI) in Drug Discovery Market, By Offering |
6.4.1 Overview and Analysis |
6.4.2 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Software, 2021- 2031F |
6.4.3 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Services, 2021- 2031F |
6.5 Oman Artificial Intelligence (AI) in Drug Discovery Market, By Indication |
6.5.1 Overview and Analysis |
6.5.2 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Immuno-Oncology, 2021- 2031F |
6.5.3 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Neurodegenerative Diseases, 2021- 2031F |
6.5.4 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.5.5 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Metabolic Diseases, 2021- 2031F |
6.5.6 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Oman Artificial Intelligence (AI) in Drug Discovery Market, By End Use |
6.6.1 Overview and Analysis |
6.6.2 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Contract Research Organizations (CROs), 2021- 2031F |
6.6.3 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.6.4 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Research Centers and Academic Institutes, 2021- 2031F |
6.6.5 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
7 Oman Artificial Intelligence (AI) in Drug Discovery Market Import-Export Trade Statistics |
7.1 Oman Artificial Intelligence (AI) in Drug Discovery Market Export to Major Countries |
7.2 Oman Artificial Intelligence (AI) in Drug Discovery Market Imports from Major Countries |
8 Oman Artificial Intelligence (AI) in Drug Discovery Market Key Performance Indicators |
8.1 Number of successful drug discoveries using AI technology |
8.2 Rate of adoption of AI tools in drug discovery processes |
8.3 Number of collaborations between pharmaceutical companies and AI technology providers |
8.4 Efficiency improvement in drug discovery timelines with AI integration |
8.5 Number of patents filed for AI-driven drug discovery technologies |
9 Oman Artificial Intelligence (AI) in Drug Discovery Market - Opportunity Assessment |
9.1 Oman Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Oman Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Oman Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Oman Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Offering, 2021 & 2031F |
9.5 Oman Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.6 Oman Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Oman Artificial Intelligence (AI) in Drug Discovery Market - Competitive Landscape |
10.1 Oman Artificial Intelligence (AI) in Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 Oman Artificial Intelligence (AI) in Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here